Cargando…

823. Clinical Outcomes of Coccidioidomycosis in Patients Requiring Intensive Care Unit Hospitalization

BACKGROUND: Coccidioidomycosis is an endemic mycosis in the southwestern United States. While most infections are mild or asymptomatic, severe cases are associated with high morbidity and mortality. We aimed to evaluate the clinical outcomes of patients admitted to the intensive care unit (ICU) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, James Ray M, Scott, Ashley, Wig, Rebecca, Tan, Rachel V, Harnois, Emily R, Zangeneh, Tirdad, Al-Obaidi, Mohanad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677040/
http://dx.doi.org/10.1093/ofid/ofad500.868
_version_ 1785150036484554752
author Lim, James Ray M
Scott, Ashley
Wig, Rebecca
Tan, Rachel V
Harnois, Emily R
Zangeneh, Tirdad
Al-Obaidi, Mohanad
author_facet Lim, James Ray M
Scott, Ashley
Wig, Rebecca
Tan, Rachel V
Harnois, Emily R
Zangeneh, Tirdad
Al-Obaidi, Mohanad
author_sort Lim, James Ray M
collection PubMed
description BACKGROUND: Coccidioidomycosis is an endemic mycosis in the southwestern United States. While most infections are mild or asymptomatic, severe cases are associated with high morbidity and mortality. We aimed to evaluate the clinical outcomes of patients admitted to the intensive care unit (ICU) with proven culture-positive coccidioidomycosis. METHODS: After institutional review board approval, we retrospectively included ICU patients with positive Coccidioides spp. culture within a multi-healthcare system between 10/01/2017 – 07/01/2022. Clinical information was collected by chart review. RESULTS: Of the 392 hospital encounters with positive Coccidioides spp. culture, 145 patients required ICU stay. The median age was 51 (32-62), with 100 (68.9%) male, 56 (38.6%) White non-Hispanics, and 25 (17.2%) Blacks. Fifty-seven (39.3%) received azole antifungals before hospitalization. Seventy-two (49.7%) had another fungal, bacterial, or viral infection during their hospitalization, and 41 (28.3%) had extrapulmonary coccidioidomycosis. The majority, 131 (90.3%), received antifungal therapy during their hospital stay. The median hospital length of stay was 18 days (10-37). Almost half (48.3%) died during the study period, with liver cirrhosis and age ( >60 years) resulting in statistically significant mortality, 12/13 (92.3%), p-value < 0.001, and 31/43 (72.1%) p-value =0.001, respectively. Mechanical ventilation and/or intravenous vasopressor support was associated with a high risk of mortality 66/113 (58.4%, p-value=< 0.001). Failure to receive antifungal therapy before ICU admission was associated with increased mortality, 46/70 (65.7%, p-value=0.002). CONCLUSION: Patients with coccidioidomycosis admitted to the ICU face an increased risk of mortality. Risk factors associated with ICU mortality include advanced age, cirrhosis, and delay in the administration of antifungal therapy. Future studies are needed to evaluate these risks further. DISCLOSURES: Tirdad Zangeneh, DO, AiCuris: Grant/Research Support Mohanad Al-Obaidi, MD, MPH, La Jolla Pharmaceuticals: Honoraria
format Online
Article
Text
id pubmed-10677040
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106770402023-11-27 823. Clinical Outcomes of Coccidioidomycosis in Patients Requiring Intensive Care Unit Hospitalization Lim, James Ray M Scott, Ashley Wig, Rebecca Tan, Rachel V Harnois, Emily R Zangeneh, Tirdad Al-Obaidi, Mohanad Open Forum Infect Dis Abstract BACKGROUND: Coccidioidomycosis is an endemic mycosis in the southwestern United States. While most infections are mild or asymptomatic, severe cases are associated with high morbidity and mortality. We aimed to evaluate the clinical outcomes of patients admitted to the intensive care unit (ICU) with proven culture-positive coccidioidomycosis. METHODS: After institutional review board approval, we retrospectively included ICU patients with positive Coccidioides spp. culture within a multi-healthcare system between 10/01/2017 – 07/01/2022. Clinical information was collected by chart review. RESULTS: Of the 392 hospital encounters with positive Coccidioides spp. culture, 145 patients required ICU stay. The median age was 51 (32-62), with 100 (68.9%) male, 56 (38.6%) White non-Hispanics, and 25 (17.2%) Blacks. Fifty-seven (39.3%) received azole antifungals before hospitalization. Seventy-two (49.7%) had another fungal, bacterial, or viral infection during their hospitalization, and 41 (28.3%) had extrapulmonary coccidioidomycosis. The majority, 131 (90.3%), received antifungal therapy during their hospital stay. The median hospital length of stay was 18 days (10-37). Almost half (48.3%) died during the study period, with liver cirrhosis and age ( >60 years) resulting in statistically significant mortality, 12/13 (92.3%), p-value < 0.001, and 31/43 (72.1%) p-value =0.001, respectively. Mechanical ventilation and/or intravenous vasopressor support was associated with a high risk of mortality 66/113 (58.4%, p-value=< 0.001). Failure to receive antifungal therapy before ICU admission was associated with increased mortality, 46/70 (65.7%, p-value=0.002). CONCLUSION: Patients with coccidioidomycosis admitted to the ICU face an increased risk of mortality. Risk factors associated with ICU mortality include advanced age, cirrhosis, and delay in the administration of antifungal therapy. Future studies are needed to evaluate these risks further. DISCLOSURES: Tirdad Zangeneh, DO, AiCuris: Grant/Research Support Mohanad Al-Obaidi, MD, MPH, La Jolla Pharmaceuticals: Honoraria Oxford University Press 2023-11-27 /pmc/articles/PMC10677040/ http://dx.doi.org/10.1093/ofid/ofad500.868 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Lim, James Ray M
Scott, Ashley
Wig, Rebecca
Tan, Rachel V
Harnois, Emily R
Zangeneh, Tirdad
Al-Obaidi, Mohanad
823. Clinical Outcomes of Coccidioidomycosis in Patients Requiring Intensive Care Unit Hospitalization
title 823. Clinical Outcomes of Coccidioidomycosis in Patients Requiring Intensive Care Unit Hospitalization
title_full 823. Clinical Outcomes of Coccidioidomycosis in Patients Requiring Intensive Care Unit Hospitalization
title_fullStr 823. Clinical Outcomes of Coccidioidomycosis in Patients Requiring Intensive Care Unit Hospitalization
title_full_unstemmed 823. Clinical Outcomes of Coccidioidomycosis in Patients Requiring Intensive Care Unit Hospitalization
title_short 823. Clinical Outcomes of Coccidioidomycosis in Patients Requiring Intensive Care Unit Hospitalization
title_sort 823. clinical outcomes of coccidioidomycosis in patients requiring intensive care unit hospitalization
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677040/
http://dx.doi.org/10.1093/ofid/ofad500.868
work_keys_str_mv AT limjamesraym 823clinicaloutcomesofcoccidioidomycosisinpatientsrequiringintensivecareunithospitalization
AT scottashley 823clinicaloutcomesofcoccidioidomycosisinpatientsrequiringintensivecareunithospitalization
AT wigrebecca 823clinicaloutcomesofcoccidioidomycosisinpatientsrequiringintensivecareunithospitalization
AT tanrachelv 823clinicaloutcomesofcoccidioidomycosisinpatientsrequiringintensivecareunithospitalization
AT harnoisemilyr 823clinicaloutcomesofcoccidioidomycosisinpatientsrequiringintensivecareunithospitalization
AT zangenehtirdad 823clinicaloutcomesofcoccidioidomycosisinpatientsrequiringintensivecareunithospitalization
AT alobaidimohanad 823clinicaloutcomesofcoccidioidomycosisinpatientsrequiringintensivecareunithospitalization